• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    January AI Raises $8.8 Million in New Funding

    FDA Clears Ava Fertility Tracking Wearable Device

    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System

    Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably

    Japan to Lead APAC Assisted Reproductive Technology Devices Market
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Seeking a Revolution in Clinical Care Through AI

    Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit

    Addition by Subtraction: The Latest of Machining for Medtech

    Innovation Incubators: An R&D Roundtable

    Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Rethink Your Medtech ASC Strategy, Part 1

    Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

    Tips for Reigniting Your MDR/IVDR Preparation

    Three Major Innovation Opportunities for Biomedical Textiles

    Use Vertical Integration to Increase Productivity, Drive Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    PTI Engineered Plastics Inc.

    Spectrum Plastics Group

    K-Tube Technologies

    Forefront Medical Technology

    MW Life Sciences
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services

    The 8 Major Types of PPE Supply Chain Fraud
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medicoil

    Unicep

    FUTEK Advanced Sensor Technology Inc.

    Concise Engineering

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Medtronic Sees Revenue Losses Due to COVID-19 Pandemic

    The company says it is well positioned for recovery.

    Medtronic Sees Revenue Losses Due to COVID-19 Pandemic
    Given the progression of COVID-19 around the world and the timing of the company’s fiscal quarter, Medtronic’s fourth quarter financial results will reflect an additional month of impact compared to many other companies who operate on a calendar-based fiscal year. Image courtesy of Medtronic.
    Related CONTENT
    • Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020
    • South Korean HIV Testing to Reach Peak Market Value This Year
    • Quidel Opens New Manufacturing Facility to Boost COVID-19 Antigen Test Production
    • 4 Trends Driving Medical Manufacturing in 2021
    • Pioneering AI Solutions to Reinforce Healthcare Services
    Globe Newswire04.22.20
    On April 21 Medtronic plc provided an update on its response to the COVID-19 pandemic, the impact on its business, and its strong financial position.
     
    First and foremost, Medtronic has taken a number of steps to help ensure the health and well-being of its more than 90,000 employees and their families around the globe. Second, the company has mobilized its global resources to support patients and physicians in this time of need, including a rapid expansion in the production and distribution of critical products in the fight against COVID-19. Third, Medtronic is partnering with key government agencies and providing direct support to communities around the world.
     
    “I am incredibly proud of the response of our 90,000 global employees. Our resolve to alleviate pain, restore health, and extend life, as outlined in our mission, has never been greater,” said Omar Ishrak, Medtronic chairman and CEO. “I want to recognize and thank our customers, partners, and the healthcare community at large, for their efforts to combat this pandemic. Individually, and collectively, we will persevere.”
     
    Employees
    Medtronic employees continue to work during this pandemic, making critical, lifesaving products to treat both COVID-19 and non-COVID-19 conditions. The company’s manufacturing and distribution facilities are routinely cleaned and sanitized, employees are utilizing personal protective equipment (PPE) and social distancing, including staggered breaks to reduce crowds in common areas, and additional screening and access protocols have been implemented. Field employees who continue to work in clinical settings are provided access to PPE. Importantly, Medtronic has also developed and rolled out to its US employees, and their family members, a free virtual COVID-19 evaluation and monitoring tool through its Care Management Services business.


    Curious how medtech's top companies are responding to the COVID-19 pandemic? Get insights into each company's actions by clicking here.

    Impact on Business
    The impact of COVID-19 on Medtronic’s businesses remains fluid, and the company continues to actively monitor the dynamic situation. Medtronic expects COVID-19 to negatively affect its fiscal fourth quarter financial results, which ends on April 24, 2020. Given the progression of COVID-19 around the world and the timing of the company’s fiscal quarter, Medtronic’s fourth quarter financial results will reflect an additional month of impact compared to many other companies who operate on a calendar-based fiscal year.
     
    Hospital resources have been diverted to fight the pandemic, and many government agencies in conjunction with healthcare systems have made decisions to defer many elective and semi-elective procedures that use the company’s products. In addition, some people are avoiding seeking treatment for non-COVID-19 emergency procedures, resulting in an impact to those emergent product lines. Capital equipment purchases, outside of ventilators and patient monitoring equipment, are also being deferred by hospitals in the current environment.
     
    The following table lists Medtronic’s businesses and therapies that might be considered more urgent, moderately elective, and more elective during the current pandemic:
     
      More Urgent Moderately Elective More Elective
    Cardiac and Vascular Group
    • Pacing
    • Aortic
    • Coronary
    • Cardiac Surgery
    • ICDs/CRT-Ds
    • TAVR/Structural Heart
    • Peripheral
    • AF Solutions
    • EndoVenous
    • Diagnostics
    Minimally Invasive Therapies Group
    • Surgical Innovations: appendectomy, bowel obstruction, trauma
    •  Respiratory and Patient Monitoring
    •  Renal Care
    • Surgical Innovations: CABG, oncology
    • Surgical Innovations: bariatric, hysterectomy, hernia
    • GI
    Restorative Therapies Group
    • Spine: Trauma
    • Neurovascular: ischemic stroke
    • Brain Modulation
    • Neurovascular: hemorrhagic stroke
    • Spine
    • Pain Therapies
    • Pelvic Health
    • ENT
    Diabetes Group
    • Diabetes supplies
     
    • New insulin pump starts

    While the vast majority of Medtronic’s businesses have experienced declines as a result of COVID-19, product lines in the cardiac and vascular, minimally invasive therapies, and diabetes groups are in high demand as a result of COVID-19.
     
    Medtronic also provided insight into the impact of COVID-19 on its business in major geographies, highlighting declines of similar magnitude to those discussed by other medical device companies in the month of February in China and Asia Pacific, in March in Western Europe and the United States, and in forward-looking comments on calendar second quarters of April through June.
     
    In China, which represented approximately 7% of total company revenue pre-COVID-19, the company expects to experience the impact of COVID-19 to its revenue for the entire fiscal fourth quarter. On average, weekly revenue declined approximately 50% year-over-year through the week of March 9. Since that time, the company’s weekly revenue has declined on average approximately 20% to 40% year-over-year, as the market is experiencing a slow recovery.
     
    In Western Europe, which represented approximately 20% of total company revenue pre-COVID-19, the company began to see an impact to revenue from COVID-19 the week of March 23. Over the last few weeks, the company’s weekly revenue has declined approximately 20% to 30% year-over-year on average, excluding any impact from customer bulk purchases.
     
    In the United States, which represented approximately 53% of total company revenue pre-COVID-19, the company began to see an impact to revenue from COVID-19 the week of March 16. Over the last few weeks, the company’s U.S. weekly revenue has declined approximately 60% year-over-year on average, excluding any impact from customer bulk purchases.
     
    In the rest of the world, which represents the remaining 20 percent of total company revenue, Medtronic saw varying degrees of impact, with the last few weeks declining on average approximately 40% to 50% year-over-year.
     
    In addition to the impact to its revenue from procedure volume declines, the company expects an incremental negative impact to revenue from a decline in typical large, end of Medtronic fiscal year customer orders as customers prioritize preservation of cash and reduce their holdings of purchased product inventories, especially in more elective procedure categories, as well as purchases of certain capital equipment.
     
    In general, the company continues to make progress with its pipeline and continues to work with regulatory agencies on timelines that do not appear to be currently affected by the pandemic. Clinical trials that are currently enrolling patients, however, have generally been placed on temporary pause to allow hospital clinical resources to focus on fighting COVID-19.
     
    Financial Position
    Medtronic says it is positioned well for times such as these. The company currently has ample liquidity, with approximately $11 billion in cash and investments as of the most recent quarter, and an undrawn $3.5 billion credit facility. The company has no public debt maturing until March 2021.
     
    Given its strong financial position, Medtronic is continuing to focus on making capital allocation decisions to drive its long-term strategies, including investing in its employees and its pipeline, as well as actively looking for tuck-in acquisition opportunities and paying a strong dividend to its shareholders.
     
    “While the expected short-term impact to our financial results is significant, it is consistent with the impact discussion broadly across the medical device industry,” said Geoff Martha, Medtronic president. “Importantly, we are starting to enter the early stages of a global recovery. As hospitals begin to resume broader treatment of non-COVID-19 patients around the world, we expect our business to begin to recover as well. In addition, given the financial strength of the company, we are executing strategies to come out of this pandemic even stronger, attracting and retaining top talent and increasing and innovating the products and services that we offer physicians, patients, and healthcare systems to win in the evolving marketplace.”
    Related Searches
    • medtronic
    • tavr
    • first
    • medical device
    Suggested For You
    Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020 Global Medical Device Venture Financing Deals Total $3.84 Billion in Q4 2020
    South Korean HIV Testing to Reach Peak Market Value This Year South Korean HIV Testing to Reach Peak Market Value This Year
    Quidel Opens New Manufacturing Facility to Boost COVID-19 Antigen Test Production Quidel Opens New Manufacturing Facility to Boost COVID-19 Antigen Test Production
    4 Trends Driving Medical Manufacturing in 2021 4 Trends Driving Medical Manufacturing in 2021
    Pioneering AI Solutions to Reinforce Healthcare Services Pioneering AI Solutions to Reinforce Healthcare Services
    BD Earns EUA, CE Mark for Combo SARS-CoV-2, Influenza A+B Test BD Earns EUA, CE Mark for Combo SARS-CoV-2, Influenza A+B Test
    Cybersecurity Measures are Crucial as COVID-19 Drives Adoption of Remote Access Devices Cybersecurity Measures are Crucial as COVID-19 Drives Adoption of Remote Access Devices
    Evolving Trends in the Medical and Orthopedic Devices Industry Evolving Trends in the Medical and Orthopedic Devices Industry
    Report: Emergency Use Authorization a Top Health Hazard for 2021 Report: Emergency Use Authorization a Top Health Hazard for 2021
    Avacta Group and Mologic Enter Commercial Partnership Avacta Group and Mologic Enter Commercial Partnership
    Machine Learning Tool Predicts Respiratory Failure in COVID-19 Patients Machine Learning Tool Predicts Respiratory Failure in COVID-19 Patients
    Pulse Biosciences Granted CE Mark Approval for CellFX System Pulse Biosciences Granted CE Mark Approval for CellFX System
    North American Medtech Deals Fall 17 Percent in Q4 2020 North American Medtech Deals Fall 17 Percent in Q4 2020
    Cretex Companies CEO Steps Down Cretex Companies CEO Steps Down
    Endoscopic Hemostasis Devices Market Valued at $730 Million Endoscopic Hemostasis Devices Market Valued at $730 Million

    Related Breaking News

    • Chronic Disease
      January AI Raises $8.8 Million in New Funding

      January AI Raises $8.8 Million in New Funding

      New technology can predict users’ glycemic response to over 16 million foods in its proprietary atlas.
      Charles Sternberg, Assistant Editor 02.26.21

    • FDA Clears Ava Fertility Tracking Wearable Device

      FDA Clears Ava Fertility Tracking Wearable Device

      The wearable is clinically proven as effective as LH tests in predicting ovulation—and with more fertile days detected.
      Michael Barbella, Managing Editor 02.26.21

    • First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System

      First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System

      The product received CE Mark approval in January.
      Michael Barbella, Managing Editor 02.26.21


    • Digital Health
      Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably

      Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably

      The FDA’s five-part action plan is expected to drive the surge.
      Michael Barbella, Managing Editor 02.26.21

    • Japan to Lead APAC Assisted Reproductive Technology Devices Market

      Japan to Lead APAC Assisted Reproductive Technology Devices Market

      Sector forecast to grow 2.1 percent annually this decade.
      Michael Barbella, Managing Editor 02.25.21

    • Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification

      Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification

      Meet the highest quality standards for manufacturing.
      Charles Sternberg, Assistant Editor 02.25.21


    • Cardiovascular
      FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump

      FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump

      Puzzle Medical Device's ModulHeart helps patients avoid open-heart surgery and reduces blood trauma.
      Michael Barbella, Managing Editor 02.25.21

    • Canada Authorizes COVID-19 Diagnostic Assay That Boosts Virus Testing Efficiency

      Canada Authorizes COVID-19 Diagnostic Assay That Boosts Virus Testing Efficiency

      The product is compatible with Thermo Fisher Scientific's Amplitude platform.
      Michael Barbella, Managing Editor 02.25.21

    • Digital Health
      Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences

      Terumo to Purchase Predictive Analytics Firm Health Outcomes Sciences

      Will enable personalized, predictive insights at the point of care.
      Sam Brusco, Associate Editor 02.24.21


    • Abiomed Leader Michael Minogue Named AdvaMed Board Chairman

      Abiomed Leader Michael Minogue Named AdvaMed Board Chairman

      He succeeds Stryker Chairman and CEO Kevin Lobo.
      Sam Brusco, Associate Editor 02.24.21

    • Surgical
      TransEnterix Changes Name to Asensus Surgical

      TransEnterix Changes Name to Asensus Surgical

      The rebranded firm also introduced a new surgical category—performance-guided surgery.
      Sam Brusco, Associate Editor 02.24.21

    • Previon, Spectrum Solutions Partner to Deliver At-Home COVID-19 Test

      Previon, Spectrum Solutions Partner to Deliver At-Home COVID-19 Test

      The pair will create and deliver COVID-19 PCR test kits to essential workers and at-risk populations.
      Michael Barbella, Managing Editor 02.24.21


    • Cardiovascular
      NTT Research, Japanese Entity to Collaborate on Cardiovascular Disease Interventions

      NTT Research, Japanese Entity to Collaborate on Cardiovascular Disease Interventions

      NCVC in Japan will develop computational models while NTT Research MEI Lab will implement a bio digital twin platform.
      Michael Barbella, Managing Editor 02.24.21

    • Global Peripheral Intravenous Catheter Market to Reach $7.5 Billion by 2027

      Global Peripheral Intravenous Catheter Market to Reach $7.5 Billion by 2027

      The rise in chronic and life-threatening diseases will help drive the growth.
      Michael Barbella, Managing Editor 02.24.21

    • Diagnostics
      SpinTech Inc. Acquires MR Innovations

      SpinTech Inc. Acquires MR Innovations

      Includes an expert team of engineers and physicists and MR Innovations' patents, published papers and network of global collaborators.
      Charles Sternberg, Assistant Editor 02.24.21


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • FDA Breakthrough Device Designation Given To MI Transcatheter Heart Pump
    • Refurbished Medical Equipment Testing And Certification Under The NEC
    Breaking News
    • January AI Raises $8.8 Million in New Funding
    • FDA Clears Ava Fertility Tracking Wearable Device
    • First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    • Artificial Intelligence, Machine Learning Adoption in Healthcare to Grow Considerably
    • Japan to Lead APAC Assisted Reproductive Technology Devices Market
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Seeking a Revolution in Clinical Care Through AI
    • Diversifying Supply Chains: New Opportunities Post Pandemic and After Brexit
    • Addition by Subtraction: The Latest of Machining for Medtech
    • Innovation Incubators: An R&D Roundtable
    • Virtual Allies: Electronics Manufacturing Services Providers Offer Real Solutions
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet
    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    What You're Reading on Happi.com
    Cosmetic Chemical Sales To Post CAGR 5.8% To 2025
    ACI Urges Senate to Approve Regan as EPA Administrator
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login